#None #biopharmaceuticals #Market Growth #Single-use Bioprocessing

The Single-Use Bioprocessing Market: Significant Growth Ahead

Introduction

The global single-use bioprocessing market is on a substantial growth trajectory, with its valuation expected to escalate from $16.51 billion in 2024 to a staggering $33.67 billion by 2030. This remarkable rise signifies a Compound Annual Growth Rate (CAGR) of 13.3%, fueled by various factors driving industry demand and capabilities.

Current Market Landscape

As of 2025, the market value was at $18.01 billion, indicating a robust start ahead of the projected growth phase. Key sectors contributing to this growth include Contract Development Manufacturing Organizations (CDMOs) and Contract Manufacturing Organizations (CMOs), both of which are increasingly adopting single-use technologies. Benefits such as enhanced productivity and minimized risk of cross-contamination further support this shift.

Alongside these factors, the biologics and biosimilars markets are experiencing significant growth, serving as boosters for the single-use bioprocessing market. The demand harkens towards lower capital investments and operational flexibility, ensuring companies tackle emerging challenges with pragmatic solutions.

Regional Insights

In terms of geography, the market is analyzed across six primary regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America is currently the market leader, driven by substantial investments in pharmaceutical research and development. The United States stands out as a key player, holding the largest share of the market due to its leadership in biopharmaceutical research and a well-established healthcare framework.

The focus on quality and safety in biopharmaceutical manufacturing continues to incite an upsurge in the demand for single-use bioprocessing products across North America, ensuring high standards are consistently met.

Product Segmentation

Within the single-use bioprocessing domain, the market is categorized into equipment and consumables. Among these, the consumables segment is projected to witness the highest growth rate throughout the forecast period. The preference for consumables can be attributed to frequent repurchase patterns and their extensive application range, which enhances their demand in the industry significantly.

Additionally, the adoption of single-use technologies as a means to mitigate cross-contamination risks is a critical factor driving this consumables segment.

Application Areas

Various applications dominate the single-use bioprocessing market, including cell culture, filtration, purification, mixing, and storage/transfer. Specifically, the filtration segment leads in terms of market share, largely due to its critical role in the pharmaceutical sector. The rising need for robust filtration solutions enhances the opportunity for advanced filtration systems, further driving market growth.

Key Players in the Market

Several established players are leading the single-use bioprocessing market, notably:

• - Sartorius AG (Germany)
• - Danaher Corporation (US)
• - Thermo Fisher Scientific, Inc. (US)
• - Merck KGaA (Germany)
• - Avantor, Inc. (US)
• - Repligen Corporation (US)
• - Entegris (US)

These organizations are constantly innovating and investing in research and development to solidify their positions. For example, Merck KGaA is actively enhancing its global footprint by delivering high-quality products and investing in new manufacturing capacities across regions, ensuring a steady supply of bioprocessing solutions.

Similarly, Danaher Corporation, following its acquisition of Pall Corporation, now leverages the strengths of its subsidiary Cytiva to maintain a competitive edge, focusing on innovative solutions tailored for local biopharmaceutical companies.

Conclusion

The single-use bioprocessing market is poised for an exciting future, with a forecasted valuation of US$33.67 billion by 2030. With innovation, strategic investments, and an increasing focus on quality and safety, the market will continue to thrive. Companies adept at adapting to these trends will undoubtedly navigate the evolving landscape successfully.

For more details and updates on this thriving industry, stay tuned.